Opioid Induced Constipation (OIC) Drugs Market Report

China Opioid Induced Constipation (OIC) Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 22, 2022
  • PAGES：176
  • REPORT CODE：GMM1084072
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Opioid Induced Constipation (OIC) Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Opioid Induced Constipation (OIC) Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Opioid Induced Constipation (OIC) Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Purdue Pharma

    • SLA Pharma AG

    • Allergan Plc

    • Ironwood Pharmaceuticals Inc

    • Theravance Biopharma Inc

    • Daewoong Pharmaceutical

    • Daiichi Sankyo Co Ltd

    • Mundipharma International Limited

    • Ono Pharmaceutical Co, Ltd

    • Takeda Pharmaceutical Company Limited

    • Sucampo Pharmaceuticals

    • Cosmo Pharmaceuticals SA

    • Progenics Pharmaceuticals Inc

    • Nektar Therapeutics

    • Shionogi & Co, Ltd

    • Pfizer

    • Valeant Pharmaceuticals International

    • CB Fleet Company

    By Type:

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Induced Constipation (OIC) Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Lubiprostone from 2016 to 2027

    • 1.3.2 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2016 to 2027

    • 1.3.3 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Naldemedine from 2016 to 2027

    • 1.3.4 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Alvimopan from 2016 to 2027

    • 1.3.5 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • 1.4.2 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • 1.4.3 China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Opioid Induced Constipation (OIC) Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid Induced Constipation (OIC) Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Lubiprostone

    • 3.4.2 Market Size and Growth Rate of Methyl Naltrexone Bromide

    • 3.4.3 Market Size and Growth Rate of Naldemedine

    • 3.4.4 Market Size and Growth Rate of Alvimopan

    • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Opioid Induced Constipation (OIC) Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid Induced Constipation (OIC) Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Opioid Induced Constipation (OIC) Drugs in Hospital Pharmacies

    • 4.4.2 Market Size and Growth Rate of Opioid Induced Constipation (OIC) Drugs in Retail Pharmacies

    • 4.4.3 Market Size and Growth Rate of Opioid Induced Constipation (OIC) Drugs in Online Pharmacies

    5 Market Analysis by Regions

    • 5.1 China Opioid Induced Constipation (OIC) Drugs Production Analysis by Regions

    • 5.2 China Opioid Induced Constipation (OIC) Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Opioid Induced Constipation (OIC) Drugs Landscape Analysis

    • 6.1 North China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major Types

    • 6.2 North China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major End-Users

    7 Central China Opioid Induced Constipation (OIC) Drugs Landscape Analysis

    • 7.1 Central China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major Types

    • 7.2 Central China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major End-Users

    8 South China Opioid Induced Constipation (OIC) Drugs Landscape Analysis

    • 8.1 South China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major Types

    • 8.2 South China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major End-Users

    9 East China Opioid Induced Constipation (OIC) Drugs Landscape Analysis

    • 9.1 East China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major Types

    • 9.2 East China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major End-Users

    10 Northeast China Opioid Induced Constipation (OIC) Drugs Landscape Analysis

    • 10.1 Northeast China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major Types

    • 10.2 Northeast China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major End-Users

    11 Southwest China Opioid Induced Constipation (OIC) Drugs Landscape Analysis

    • 11.1 Southwest China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major Types

    • 11.2 Southwest China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major End-Users

    12 Northwest China Opioid Induced Constipation (OIC) Drugs Landscape Analysis

    • 12.1 Northwest China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major Types

    • 12.2 Northwest China Opioid Induced Constipation (OIC) Drugs Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Purdue Pharma

      • 13.1.1 Purdue Pharma Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 SLA Pharma AG

      • 13.2.1 SLA Pharma AG Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Allergan Plc

      • 13.3.1 Allergan Plc Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Ironwood Pharmaceuticals Inc

      • 13.4.1 Ironwood Pharmaceuticals Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Theravance Biopharma Inc

      • 13.5.1 Theravance Biopharma Inc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Daewoong Pharmaceutical

      • 13.6.1 Daewoong Pharmaceutical Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Daiichi Sankyo Co Ltd

      • 13.7.1 Daiichi Sankyo Co Ltd Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Mundipharma International Limited

      • 13.8.1 Mundipharma International Limited Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Ono Pharmaceutical Co, Ltd

      • 13.9.1 Ono Pharmaceutical Co, Ltd Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Takeda Pharmaceutical Company Limited

      • 13.10.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Sucampo Pharmaceuticals

      • 13.11.1 Sucampo Pharmaceuticals Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Cosmo Pharmaceuticals SA

      • 13.12.1 Cosmo Pharmaceuticals SA Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Progenics Pharmaceuticals Inc

      • 13.13.1 Progenics Pharmaceuticals Inc Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Nektar Therapeutics

      • 13.14.1 Nektar Therapeutics Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 Shionogi & Co, Ltd

      • 13.15.1 Shionogi & Co, Ltd Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    • 13.16 Pfizer

      • 13.16.1 Pfizer Company Profile and Recent Development

      • 13.16.2 Market Performance

      • 13.16.3 Product and Service Introduction

    • 13.17 Valeant Pharmaceuticals International

      • 13.17.1 Valeant Pharmaceuticals International Company Profile and Recent Development

      • 13.17.2 Market Performance

      • 13.17.3 Product and Service Introduction

    • 13.18 CB Fleet Company

      • 13.18.1 CB Fleet Company Company Profile and Recent Development

      • 13.18.2 Market Performance

      • 13.18.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Lubiprostone from 2016 to 2027

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2016 to 2027

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Naldemedine from 2016 to 2027

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Alvimopan from 2016 to 2027

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • Figure China Opioid Induced Constipation (OIC) Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Opioid Induced Constipation (OIC) Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Opioid Induced Constipation (OIC) Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid Induced Constipation (OIC) Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Opioid Induced Constipation (OIC) Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Methyl Naltrexone Bromide

    • Figure Market Size and Growth Rate of Naldemedine

    • Figure Market Size and Growth Rate of Alvimopan

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Opioid Induced Constipation (OIC) Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Opioid Induced Constipation (OIC) Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table China Opioid Induced Constipation (OIC) Drugs Production by Regions

    • Table China Opioid Induced Constipation (OIC) Drugs Production Share by Regions

    • Figure China Opioid Induced Constipation (OIC) Drugs Production Share by Regions in 2016

    • Figure China Opioid Induced Constipation (OIC) Drugs Production Share by Regions in 2021

    • Figure China Opioid Induced Constipation (OIC) Drugs Production Share by Regions in 2027

    • Table China Opioid Induced Constipation (OIC) Drugs Consumption by Regions

    • Table China Opioid Induced Constipation (OIC) Drugs Consumption Share by Regions

    • Figure China Opioid Induced Constipation (OIC) Drugs Consumption Share by Regions in 2016

    • Figure China Opioid Induced Constipation (OIC) Drugs Consumption Share by Regions in 2021

    • Figure China Opioid Induced Constipation (OIC) Drugs Consumption Share by Regions in 2027

    • Table North China Opioid Induced Constipation (OIC) Drugs Consumption by Types from 2016 to 2027

    • Table North China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types from 2016 to 2027

    • Figure North China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2016

    • Figure North China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2021

    • Figure North China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2027

    • Table North China Opioid Induced Constipation (OIC) Drugs Consumption by End-Users from 2016 to 2027

    • Table North China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure North China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2016

    • Figure North China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2021

    • Figure North China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2027

    • Table Central China Opioid Induced Constipation (OIC) Drugs Consumption by Types from 2016 to 2027

    • Table Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types from 2016 to 2027

    • Figure Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2016

    • Figure Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2021

    • Figure Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2027

    • Table Central China Opioid Induced Constipation (OIC) Drugs Consumption by End-Users from 2016 to 2027

    • Table Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2016

    • Figure Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2021

    • Figure Central China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2027

    • Table South China Opioid Induced Constipation (OIC) Drugs Consumption by Types from 2016 to 2027

    • Table South China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types from 2016 to 2027

    • Figure South China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2016

    • Figure South China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2021

    • Figure South China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2027

    • Table South China Opioid Induced Constipation (OIC) Drugs Consumption by End-Users from 2016 to 2027

    • Table South China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2016

    • Figure South China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2021

    • Figure South China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2027

    • Table East China Opioid Induced Constipation (OIC) Drugs Consumption by Types from 2016 to 2027

    • Table East China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types from 2016 to 2027

    • Figure East China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2016

    • Figure East China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2021

    • Figure East China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2027

    • Table East China Opioid Induced Constipation (OIC) Drugs Consumption by End-Users from 2016 to 2027

    • Table East China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure East China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2016

    • Figure East China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2021

    • Figure East China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2027

    • Table Northeast China Opioid Induced Constipation (OIC) Drugs Consumption by Types from 2016 to 2027

    • Table Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2016

    • Figure Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2021

    • Figure Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2027

    • Table Northeast China Opioid Induced Constipation (OIC) Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2016

    • Figure Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2021

    • Figure Northeast China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2027

    • Table Southwest China Opioid Induced Constipation (OIC) Drugs Consumption by Types from 2016 to 2027

    • Table Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2016

    • Figure Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2021

    • Figure Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2027

    • Table Southwest China Opioid Induced Constipation (OIC) Drugs Consumption by End-Users from 2016 to 2027

    • Table Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2016

    • Figure Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2021

    • Figure Southwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2027

    • Table Northwest China Opioid Induced Constipation (OIC) Drugs Consumption by Types from 2016 to 2027

    • Table Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2016

    • Figure Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2021

    • Figure Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by Types in 2027

    • Table Northwest China Opioid Induced Constipation (OIC) Drugs Consumption by End-Users from 2016 to 2027

    • Table Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2016

    • Figure Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2021

    • Figure Northwest China Opioid Induced Constipation (OIC) Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of SLA Pharma AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SLA Pharma AG

    • Figure Sales and Growth Rate Analysis of SLA Pharma AG

    • Figure Revenue and Market Share Analysis of SLA Pharma AG

    • Table Product and Service Introduction of SLA Pharma AG

    • Table Company Profile and Development Status of Allergan Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan Plc

    • Figure Sales and Growth Rate Analysis of Allergan Plc

    • Figure Revenue and Market Share Analysis of Allergan Plc

    • Table Product and Service Introduction of Allergan Plc

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals Inc

    • Table Product and Service Introduction of Ironwood Pharmaceuticals Inc

    • Table Company Profile and Development Status of Theravance Biopharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance Biopharma Inc

    • Figure Sales and Growth Rate Analysis of Theravance Biopharma Inc

    • Figure Revenue and Market Share Analysis of Theravance Biopharma Inc

    • Table Product and Service Introduction of Theravance Biopharma Inc

    • Table Company Profile and Development Status of Daewoong Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical

    • Table Product and Service Introduction of Daewoong Pharmaceutical

    • Table Company Profile and Development Status of Daiichi Sankyo Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co Ltd

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co Ltd

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo Co Ltd

    • Table Product and Service Introduction of Daiichi Sankyo Co Ltd

    • Table Company Profile and Development Status of Mundipharma International Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma International Limited

    • Figure Sales and Growth Rate Analysis of Mundipharma International Limited

    • Figure Revenue and Market Share Analysis of Mundipharma International Limited

    • Table Product and Service Introduction of Mundipharma International Limited

    • Table Company Profile and Development Status of Ono Pharmaceutical Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ono Pharmaceutical Co, Ltd

    • Figure Sales and Growth Rate Analysis of Ono Pharmaceutical Co, Ltd

    • Figure Revenue and Market Share Analysis of Ono Pharmaceutical Co, Ltd

    • Table Product and Service Introduction of Ono Pharmaceutical Co, Ltd

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

    • Table Company Profile and Development Status of Sucampo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals

    • Table Product and Service Introduction of Sucampo Pharmaceuticals

    • Table Company Profile and Development Status of Cosmo Pharmaceuticals SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals SA

    • Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals SA

    • Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals SA

    • Table Product and Service Introduction of Cosmo Pharmaceuticals SA

    • Table Company Profile and Development Status of Progenics Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals Inc

    • Table Product and Service Introduction of Progenics Pharmaceuticals Inc

    • Table Company Profile and Development Status of Nektar Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

    • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Product and Service Introduction of Nektar Therapeutics

    • Table Company Profile and Development Status of Shionogi & Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi & Co, Ltd

    • Figure Sales and Growth Rate Analysis of Shionogi & Co, Ltd

    • Figure Revenue and Market Share Analysis of Shionogi & Co, Ltd

    • Table Product and Service Introduction of Shionogi & Co, Ltd

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International

    • Table Product and Service Introduction of Valeant Pharmaceuticals International

    • Table Company Profile and Development Status of CB Fleet Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CB Fleet Company

    • Figure Sales and Growth Rate Analysis of CB Fleet Company

    • Figure Revenue and Market Share Analysis of CB Fleet Company

    • Table Product and Service Introduction of CB Fleet Company


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US